AFYREN SAS (ALAFY.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALAFY • FR0014005AC9

2.985 EUR
+0.03 (+1.19%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, ALAFY scores 3 out of 10 in our fundamental rating. ALAFY was compared to 68 industry peers in the Chemicals industry. ALAFY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALAFY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ALAFY has reported negative net income.
  • ALAFY had a negative operating cash flow in the past year.
  • In the past 5 years ALAFY always reported negative net income.
  • In the past 5 years ALAFY always reported negative operating cash flow.
ALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

  • ALAFY's Return On Assets of -22.07% is on the low side compared to the rest of the industry. ALAFY is outperformed by 83.82% of its industry peers.
  • With a Return On Equity value of -24.60%, ALAFY is not doing good in the industry: 80.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -22.07%
ROE -24.6%
ROIC N/A
ROA(3y)-13.7%
ROA(5y)-10.19%
ROE(3y)-15.66%
ROE(5y)-12.5%
ROIC(3y)N/A
ROIC(5y)N/A
ALAFY.PA Yearly ROA, ROE, ROICALAFY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • ALAFY has a better Gross Margin (89.71%) than 100.00% of its industry peers.
  • ALAFY's Gross Margin has declined in the last couple of years.
  • ALAFY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-1.95%
ALAFY.PA Yearly Profit, Operating, Gross MarginsALAFY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ALAFY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALAFY has more shares outstanding
  • Compared to 5 years ago, ALAFY has more shares outstanding
  • The debt/assets ratio for ALAFY has been reduced compared to a year ago.
ALAFY.PA Yearly Shares OutstandingALAFY.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALAFY.PA Yearly Total Debt VS Total AssetsALAFY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ALAFY has an Altman-Z score of 11.41. This indicates that ALAFY is financially healthy and has little risk of bankruptcy at the moment.
  • ALAFY has a better Altman-Z score (11.41) than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that ALAFY is not too dependend on debt financing.
  • ALAFY has a better Debt to Equity ratio (0.03) than 92.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 11.41
ROIC/WACCN/A
WACC7.97%
ALAFY.PA Yearly LT Debt VS Equity VS FCFALAFY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • ALAFY has a Current Ratio of 14.79. This indicates that ALAFY is financially healthy and has no problem in meeting its short term obligations.
  • ALAFY has a Current ratio of 14.79. This is amongst the best in the industry. ALAFY outperforms 100.00% of its industry peers.
  • A Quick Ratio of 14.79 indicates that ALAFY has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 14.79, ALAFY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.79
Quick Ratio 14.79
ALAFY.PA Yearly Current Assets VS Current LiabilitesALAFY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for ALAFY have decreased strongly by -16.24% in the last year.
  • ALAFY shows a decrease in Revenue. In the last year, the revenue decreased by -3.05%.
  • ALAFY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.31% yearly.
EPS 1Y (TTM)-16.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.81%
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y-1.95%
Revenue growth 5Y4.31%
Sales Q2Q%-11.73%

3.2 Future

  • ALAFY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.04% yearly.
  • ALAFY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 92.86% yearly.
EPS Next Y15.56%
EPS Next 2Y13.53%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue Next Year-5.8%
Revenue Next 2Y-2.94%
Revenue Next 3Y92.86%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALAFY.PA Yearly Revenue VS EstimatesALAFY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
ALAFY.PA Yearly EPS VS EstimatesALAFY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALAFY. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALAFY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAFY.PA Price Earnings VS Forward Price EarningsALAFY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAFY.PA Per share dataALAFY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • ALAFY's earnings are expected to grow with 13.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.53%
EPS Next 3Y13.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALAFY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AFYREN SAS

EPA:ALAFY (2/6/2026, 7:00:00 PM)

2.985

+0.03 (+1.19%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners8.98%
Inst Owner ChangeN/A
Ins Owners7.81%
Ins Owner ChangeN/A
Market Cap106.53M
Revenue(TTM)2.70M
Net Income(TTM)-11.36M
Analysts86
Price Target5.1 (70.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.7%
EPS NY rev (3m)24.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39.43
P/FCF N/A
P/OCF N/A
P/B 2.31
P/tB 2.46
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.08
BVpS1.29
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.07%
ROE -24.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.71%
FCFM N/A
ROA(3y)-13.7%
ROA(5y)-10.19%
ROE(3y)-15.66%
ROE(5y)-12.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-1.95%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.49%
Cap/Sales 10.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.79
Quick Ratio 14.79
Altman-Z 11.41
F-Score5
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)59.69%
Cap/Depr(5y)64.66%
Cap/Sales(3y)13.21%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.81%
EPS Next Y15.56%
EPS Next 2Y13.53%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y-1.95%
Revenue growth 5Y4.31%
Sales Q2Q%-11.73%
Revenue Next Year-5.8%
Revenue Next 2Y-2.94%
Revenue Next 3Y92.86%
Revenue Next 5YN/A
EBIT growth 1Y4.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.45%
EBIT Next 3Y13.43%
EBIT Next 5YN/A
FCF growth 1Y-10.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.16%
OCF growth 3YN/A
OCF growth 5YN/A

AFYREN SAS / ALAFY.PA FAQ

Can you provide the ChartMill fundamental rating for AFYREN SAS?

ChartMill assigns a fundamental rating of 3 / 10 to ALAFY.PA.


Can you provide the valuation status for AFYREN SAS?

ChartMill assigns a valuation rating of 0 / 10 to AFYREN SAS (ALAFY.PA). This can be considered as Overvalued.


Can you provide the profitability details for AFYREN SAS?

AFYREN SAS (ALAFY.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for AFYREN SAS?

The Earnings per Share (EPS) of AFYREN SAS (ALAFY.PA) is expected to grow by 15.56% in the next year.